摘要:
According to the present invention, no gap occurs in the joint between adjacent blocks when a design is marked in several blocks. In a liquid crystal laser marker for making a liquid crystal mask (2) with a plurality of pixels display a design to be marked on workpieces and for transmitting a laser beam through the liquid crystal mask to a workpiece so that the design will be marked on the workpiece, the liquid crystal mask is such that the pixels at all or part of the outermost sides have a size which is different from that of the inner pixels. The liquid crystal laser marker further includes a controller (11), when a design is divided into several blocks (1, 1, 1) and one of the blocks is displayed on the liquid crystal mask, the controller controls the liquid crystal mask such that a marking position of the block currently displayed on the liquid crystal mask overlaps a marking position of a block adjacent to the currently displayed block by a given length (L.sub.1, L.sub.2) of a portion where the outermost pixels have a size which is different from that of the inner pixels of the liquid crystal mask. A liquid crystal mask the pixels of which have the same size can be used. In this case, the controller controls the liquid crystal mask such that a marking position of a block currently displayed on the liquid crystal mask overlaps a marking position of a block adjacent to the currently displayed block by a given length (L3, L4) of a portion corresponding to part of the outermost pixels of the liquid crystal mask.
摘要:
This invention relates to a compound of the formula: ##STR1## wherein Z is a group of the formula: ##STR2## in which X.sup.1 is N or C--R.sup.1,X.sup.2 is N or C--R.sup.9,X.sup.3 is N or C--R.sup.2,R.sup.1 is lower alkyl,R.sup.2 is hydrogen, lower alkyl, etc.,R.sup.9 is hydrogen or lower alkyl,R.sup.3 is halogen, etc.,R.sup.4 is halogen, etc.,R.sup.5 is a group of the formula: ##STR3## A is lower alkylene, and Y is O, etc.,and pharmaceutically acceptable salts thereof, to processes for preparation thereof, to a pharmaceutical composition comprising the same, and to methods to using the same therapeutically in the prevention and/or the treatment of bradykinin or its analogues mediated diseases in human being or animals.
摘要:
This invention relates to tricyclo compounds useful for treatment and prevention of resistance by transplantation, graft-versus-host diseases by medulla ossium transplantation, autoimmune diseases, infectious diseases, and the like, which can be represented by the following formula: ##STR1## to a process for their production, to a pharmaceutical composition containing the same and to a use thereof.
摘要:
The invention relates to bradykinin antagonists of the formula: ##STR1## wherein R.sup.1 is halogen, R.sup.2 and R.sup.3 are each hydrogen, lower alkyl, halo(lower)alkyl or acyl, R.sup.4 is aryl having suitable substituent(s), or a heterocyclic group optionally having suitable substituent(s), Q is O or N--R.sup.11, in which R.sup.11 is hydrogen or acyl, and A is lower alkylene, and pharmaceutically acceptable salts thereof.
摘要:
A compound of the formula: ##STR1## or its salt is prepared by reacting a compound of the formula: ##STR2## with a compound of the formula: ##STR3## Wherein the variables are all defined in claim 1.
摘要:
A novel industrial process excellent in yield and purity for preparing a compound of the formula: ##STR1## or a salt thereof, which comprises reacting a compound of the formula: ##STR2## or a salt thereof with a compound of the formula: R.sup.3 --A--OH or its reactive derivative or a salt thereof, wherein R.sup.2 is cyclo(lower)alkyl, aryl or ar(lower)alkyl, each of which may be substituted with halogen, R.sup.3 is lower alkyl, aryl, ar(lower)alkoxy or heterocyclic group, each of which may be substituted with halogen, A is ##STR3## or lower alkylene and ##STR4##
摘要:
The present invention provides a method and a device for color laser marking for attaining visible coloring without drastic modification of conventional devices and without using dyestuffs. To this end, in a color laser marking method, a workpiece (10) is a synthetic material made from organic and inorganic materials and, when irradiating laser light, patterns in different colors can be obtained by varying the received light intensity on the workpiece (10). In addition, in a color laser marking device, when the workpiece (10) is a synthetic material made from organic and inorganic materials, a controller (11) outputs laser irradiation intensity varying signals to at least one of laser irradiation intensity varying means, such as a laser oscillator (1).
摘要:
A ringtrip judging circuit includes a single comparator for comparing a detection value of a ringing current with a threshold value and for outputting the result of the comparison, a threshold value control circuit for supplying the threshold value to the comparator, and a judging circuit for judging ringtrip based on the output of the comparator. During a prescribed period after ringing signal transmission, the threshold value control circuit changes the threshold value in a steplike manner in accordance with the result of the comparison, thereby determining a threshold value greater than a peak value during the prescribed period, and based on it, determines a threshold value for ringtrip judgement and supplies it to the comparator.
摘要:
Peptide compounds of the formula (I') ##STR1## in which R.sup.1 is acyl,R.sup.2 is lower alkyl, cyclo(lower)alkyl(lower)alkyl or optionally substituted heterocyclic(lower)alkyl,R.sup.3 is optionally substituted heterocyclic(lower)alkyl or optionally substituted ar(lower)alkyl,R.sup.4 is lower alkyl, amino(lower)alkyl, protected amino(lower)alkyl, carboxy(lower)alkyl, protected carboxy(lower)alkyl or optionally substituted heterocyclic(lower)alkyl,R.sup.5 is carboxy, protected carboxy, carboxy(lower)alkyl or protected carboxy(lower)alkyl,R.sup.6 is hydrogen, lower alkyl, C.sub.6-10 ar(lower)alkyl amino(lower)alkyl, protected amino(lower)alkyl, carboxy(lower)alkyl, protected carboxy(lower)alkyl, or heterocyclic(lower)alkyl,R.sup.7 is hydrogen or lower alkyl, andA is --O--, --NH--, lower alkylimino or lower alkylene, or a pharmaceutically acceptable salt thereof are disclosed. The compounds can be used to treat and prevent endothelin mediated diseases such as hypertension. The preparation of such peptides is also disclosed.
摘要:
This invention relates to pyrrolidine derivatives and pharmaceutically acceptable salts, their pharmaceutical compositions, and methods of use as thromboxane A.sub.2 antagonists and/or thromboxane A.sub.2 synthetase inhibitors in the treatment of thrombotic diseases, asthma or nephritis, e.g. of the formula: ##STR1## wherein R.sup.1 is thienyl(lower)alkyl, furyl(lower)alkyl or pyrrolyl(lower)alkyl.